The potential of brown-algae polysaccharides for the development of anticancer agents: An update on anticancer

K K Asanka Sanjeewa1, Jung-Suck Lee2, Won-Suck Kim3

  • 1Department of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju 63243, Republic of Korea.

Carbohydrate Polymers
|October 1, 2017
PubMed

Insights

Marine algae polysaccharides like fucoidan and laminaran show significant anticancer potential. These natural compounds offer a promising alternative to synthetic drugs, with demonstrated efficacy against various cancer cells in recent studies.

Area of Science:

  • Marine biology
  • Pharmacology
  • Oncology

Background:

  • Rising cancer mortality drives demand for novel treatments.
  • Synthetic anticancer drugs often cause adverse effects.
  • Natural compounds from marine sources offer safer alternatives.

Purpose of the Study:

  • To review the in vitro and in vivo anticancer properties of fucoidan and laminaran.
  • To summarize research on these brown seaweed polysaccharides from 2013-2016.

Main Methods:

  • Literature review of scientific studies published between 2013 and 2016.
  • Focus on in vitro and in vivo research concerning fucoidan and laminaran.
  • Analysis of anticancer effects against various cancer cell types.

Main Results:

  • Fucoidan and laminaran exhibit significant anticancer activities.
  • These polysaccharides demonstrate efficacy in both laboratory and animal models.
  • Evidence supports their potential as anticancer agents.

Conclusions:

  • Fucoidan and laminaran are promising natural compounds for cancer therapy.
  • Brown seaweed polysaccharides represent a valuable source for anticancer drug development.
  • Further research is warranted to explore their therapeutic applications.